Your browser doesn't support javascript.
loading
Fungal CYP51 Inhibitors VT-1161 and VT-1129 Exhibit Strong In Vitro Activity against Candida glabrata and C. krusei Isolates Clinically Resistant to Azole and Echinocandin Antifungal Compounds.
Schell, W A; Jones, A M; Garvey, E P; Hoekstra, W J; Schotzinger, R J; Alexander, B D.
Affiliation
  • Schell WA; Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
  • Jones AM; Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
  • Garvey EP; Viamet Pharmaceuticals, Inc., Durham, North Carolina, USA.
  • Hoekstra WJ; Viamet Pharmaceuticals, Inc., Durham, North Carolina, USA.
  • Schotzinger RJ; Viamet Pharmaceuticals, Inc., Durham, North Carolina, USA.
  • Alexander BD; Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA Barbara.alexander@dm.duke.edu.
Article in En | MEDLINE | ID: mdl-27956419

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridines / Tetrazoles / Candida / Drug Resistance, Fungal / 14-alpha Demethylase Inhibitors / Antifungal Agents Limits: Humans Language: En Journal: Antimicrob Agents Chemother Year: 2017 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridines / Tetrazoles / Candida / Drug Resistance, Fungal / 14-alpha Demethylase Inhibitors / Antifungal Agents Limits: Humans Language: En Journal: Antimicrob Agents Chemother Year: 2017 Document type: Article Affiliation country: Country of publication: